Market

How Will Medical Holography Transform Healthcare by 2029?
Management & Regulatory How Will Medical Holography Transform Healthcare by 2029?

The dawn of holography technology marks a revolutionary period in healthcare, enhancing diagnostic capabilities, surgical planning, and medical education. With predictions of the global medical holography market reaching $7.11 billion by 2029, the healthcare sector stands on the brink of profound

Can Europe's Medical Gloves Market Overcome Environmental Challenges?
Management & Regulatory Can Europe's Medical Gloves Market Overcome Environmental Challenges?

The Europe medical gloves market, valued at USD 4.35 billion in 2024, is set to grow steadily, reaching USD 7.89 billion by 2033. As healthcare demands rise, so does the reliance on medical gloves—a critical component in infection control. However, environmental concerns loom large over this

How Will Repligen's Acquisition of 908 Devices Enhance Bioprocessing?
Biotech & Bioprocessing How Will Repligen's Acquisition of 908 Devices Enhance Bioprocessing?

Repligen, an innovative leader in bioprocess technology, has made a strategic move by acquiring essential upstream Process Analytical Technology (PAT) assets from 908 Devices for a total of $70 million. This acquisition should be viewed as more than just a simple addition of technology; it

New Cancer Drugs Show Potential to Surpass Keytruda in Clinical Trials
Research & Development New Cancer Drugs Show Potential to Surpass Keytruda in Clinical Trials

The pharmaceutical industry is abuzz with excitement over a new class of cancer drugs known as PD-1/VEGF inhibitors. These promising therapies, currently undergoing clinical trials, might leapfrog Merck & Co.’s highly successful cancer immunotherapy, Keytruda. The advent of these new drugs could

Telehealth Industry Faces Shifts in Leadership, Tech, and Legal Hurdles
Tech & Innovation Telehealth Industry Faces Shifts in Leadership, Tech, and Legal Hurdles

The telehealth and telecare industries are experiencing unprecedented transformations driven by shifts in leadership, rapid technological advancements, and ongoing legal challenges. These elements are collectively redefining the landscape of healthcare delivery, compelling companies to adapt and

Will Henlius Biotech Thrive After Fosun Pharma's Failed Buyout Attempt?
Management & Regulatory Will Henlius Biotech Thrive After Fosun Pharma's Failed Buyout Attempt?

Fosun Pharmaceutical, a leading Chinese pharmaceutical conglomerate, recently attempted to take full control of its biopharma subsidiary, Henlius Biotech, by purchasing the remaining minority shares. This strategic move aimed to consolidate Henlius under Fosun's complete ownership, leveraging the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later